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Abstract
Background: Postprandial glycaemic response affects cognitive and vascular function. The acute effect of breakfast
glycaemic index on vascular parameters is not sufficiently known. Also, the influence of breakfasts with different
glycaemic index on cognitive performance has been mostly studied in children and adolescents with varying
results. Therefore, the purpose of this study is to analyse the postprandial effect of high and low glycaemic index
breakfasts on vascular function and cognitive performance and their relationship with postprandial glycaemic
response in healthy young adults.
Methods/design: This is a crossover clinical trial targeting adults (aged 20–40 years, free from cardiovascular
disease) selected by consecutive sampling at urban primary care health clinics in Salamanca (Spain). Each subject
will complete three interventions with a washout period of one week: a control condition (consisting of water); a
low glycaemic index breakfast (consisting of dark chocolate, walnuts, yogurt and an apple, with an overall glycaemic
index of 29.4 and an energy contribution of 1489 kJ); and a high glycaemic index breakfast (consisting of bread, grape
juice and strawberry jam, with an overall glycaemic index of 64.0 and an energy contribution of 1318 kJ). The
postprandial effect will be assessed at 60 and 120 minutes from each breakfast including blood sampling and
cognitive performance evaluations. Measurements of arterial stiffness and central haemodynamic parameters
will be taken at –10, 0, 15, 30, 45, 60, 75, 90, 105 and 120 minutes.
Discussion: The differences in postprandial glycaemic response due to breakfast glycaemic index could affect
vascular parameters and cognitive performance with important applications and implications for the general
population. This could provide necessary information for the establishment of new strategies in terms of
nutritional education and work performance improvement.
Trial registration: ClinicalTrials.gov: NCT02616276. Registered on 19 November 2015.
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Background
The glycaemic index (GI) is a measure of the speed with
which a carbohydrate is absorbed compared to a refer-
ence product (pure glucose) [1, 2]. Diets with a high GI
increase the risk of diseases related to lifestyles such as
type 2 diabetes mellitus [3, 4]. A recent meta-analysis of
14 prospective studies found that high GI diets are asso-
ciated with an increased risk of cardiovascular disease
(CVD) [5], while a reduction in dietary GI can
favourably affect the incidence of coronary disease in
women [6]. Low GI diets might reduce the risk of CVD
because they decrease postprandial glycaemia with dif-
ferent metabolic effects including differences in insulin
sensitivity, circulating lipid concentrations and vascular
function [3].
Regarding this latter aspect, the currently accepted
gold standard to assess arterial stiffness is the carotid-
femoral pulse wave velocity (PWV) [7], which has been
related to increased morbidity and mortality in both pa-
tients with CVD and healthy individuals [8, 9]. Likewise,
the augmentation index (AIx) is a measure of wave
reflection and arterial stiffness that has been shown to
be a predictor of both future cardiovascular events and
all-cause mortality [10]. In this way, the Lifestyles and
Vascular Aging (EVIDENT) study [11] analysed the rela-
tionship between lifestyle and arterial aging in a sample
of 1553 subjects who were free from CVD. We con-
cluded that low GI diets were associated with lower AIx
values. In this regard, a reduction in central haemo-
dynamic parameters, AIx and PWV, at 60 minutes from
food intake has been reported in healthy adults, perhaps
because of an increase in insulin and/or visceral vaso-
dilatation [12]. Another possible explanation for these
findings might be the postprandial hypotension that oc-
curs after a meal due to decreased cortisol secretion and
activation of the parasympathetic system [13]. For these
reasons, although the effects of various macronutrients
on vascular function have been explored in a number of
studies [14–17], Taylor et al. [12] underlined the import-
ance of analysing the impact of different types of meals
on parasympathetic activity, central blood pressure
(CBP) and vascular function parameters.
Of particular interest is the carbohydrate (CHO) con-
tent of a meal, which changes postprandial glucose and
insulin levels and results in varying AIx reductions in
postmenopausal women [18]. Thus, breakfast would play
a fundamental role, because traditional breakfast foods
tend to be high in CHOs, and there can be variability in
the GI of these CHOs. It appears that consuming food
early in the day can have a beneficial metabolic impact
regardless of GI and that low GI meals can be of more
value for glycaemic control in the morning than the
evening [19]. However, despite the fact that breakfast
patterns are associated with metabolic profiles [20], few
authors have studied their effect on cardiovascular re-
sponses. Ahuja et al. [21] found that a light breakfast
(1301 kJ energy) reduced AIx, CBP and blood pressure
(BP), and increased heart rate (HR) in adults versus fasting
(water). In contrast, a trial aimed to compare the dietary
effects of a high GI with a low GI breakfast replacement
in obese and overweight individuals reported no differ-
ences in BP or insulin concentration between breakfasts
together with beneficial changes in fasting glucose after
the consumption of a low GI breakfast [22].
On the other hand, increasing evidence has shown that
the postprandial glycaemic response also has a potential
impact on cognitive function [23]. Due to the import-
ance that cognitive processes have on professional devel-
opment, there is interest in examining the influence of
breakfasts with different GI values on cognitive out-
comes in healthy young adults.
Cognitive performance may be influenced by many
factors including individual and socioeconomic differ-
ences or nutritional and health status [24]. The effect
that breakfasts with different GIs may have on cognitive
performance has been studied in people with type 2 dia-
betes mellitus and obesity, but it is not clear that a specific
GI breakfast could benefit cognitive processes in these
participants [23, 25]. However, various studies conducted
on children have explored the relationship between break-
fasts consisting of different GI foods and cognitive func-
tions with contrasting results [24, 26–29]. It appears that
a low GI breakfast can benefit the immediate [28–30] and
delayed [31] verbal memory as well as sustained attention
[30] and verbal fluency [32]. A high GI breakfast may con-
fer benefits for selective attention, processing speed and
working memory [32]. In addition, consuming different
GI carbohydrates at breakfast could modulate cognitive
performance, but this effect requires more study [33].
Objectives
The present study aims to evaluate, in a sample of
healthy young adults, the postprandial effect of low and
high glycaemic index (GI) breakfasts on vascular func-
tion, as measured by central blood pressure, augmenta-
tion index and pulse wave velocity and also cognitive
performance. The secondary goal is to analyse the asso-
ciation of postprandial glycaemic response with vascular




We designed a controlled crossover clinical trial
where each subject will complete three interventions
(control condition, high GI breakfast and low GI
breakfast) with a washout period of one week between
each trial. The order will be determined by a randomisation
Sanchez-Aguadero et al. Trials  (2016) 17:516 Page 2 of 8
sequence generated using randomization.com software
(http://www.randomization.com) (Fig. 1). The SPIRIT
checklist is provided as Additional file 1.
Study setting
The study will be conducted in the primary care
health area of Salamanca in “La Alamedilla” Research
Unit belonging to the Spanish Network for Preventive
Activities and Health Promotion (redIAPP) and the
Institute of Biomedical Research of Salamanca
(IBSAL).
Study population
The subjects will be selected by consecutive sampling in
the primary care clinics of urban health centres from
Salamanca (Spain) between 2015 and 2016.
Inclusion criteria
The study targets young adults aged 20–40 years of both
sexes who agree to sign the informed consent document.
Exclusion criteria
Subjects will be excluded who have a history of cardio-
vascular events (acute myocardial infarction, stroke,
etc.), hypertension, diabetes mellitus, dyslipidaemia,
pharmacological treatment for any of these conditions,
neurological and/or neuropsychological disease or the
consumption of toxic substances. We will also exclude
patients with celiac disease and/or those intolerant to
lactose, subjects on a low-calorie and/or low-sodium
diet, pregnant women or those with any other circum-
stance that the investigators suggest will interfere with
the study procedures.
Sample size
The primary outcome variable is change in central aug-
mentation index (AIx). The Conduit Artery Function
Evaluation (CAFE) study [8] found a reduction in cardio-
vascular events associated with a decline of 6.5 (5.8, 7.3)
points in the AIx. This is the basis of our calculation. The
power calculation was a repeated measures design and
compared both intervention breakfasts with a control con-
dition with an alpha risk of 0.05 and a beta risk of 0.2. The
standard deviation (SD) was 10 with a correlation coeffi-
cient between the initial and final measurement of 0.7.
Thus, 40 subjects are required to detect a minimum dif-
ference of 5 points in the AIx between two intervention
breakfasts. A loss to follow-up of 5 % was estimated.
Study procedures
On arrival at the research unit, subjects will be
weighed, and their height, waist circumference and
hip circumference will be measured. Participants will
be seated and remain in this position throughout the
visit. After 5 minutes of rest, a peripheral blood pres-
sure measurement will be performed, and immediately
the central blood pressure and haemodynamic parameters
Fig. 1 Flowchart of breakfast glycaemic index study. BF breakfast
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will be obtained. Next, cognitive performance will be
assessed, fasting blood samples will be collected and
central blood pressure and haemodynamic parameters will
be determined again. Subjects will be provided with a
randomly assigned breakfast to be consumed within
10 minutes. At the first bite, a timer will be started and
additional measurements of central blood pressure and
haemodynamic parameters will be taken every 15 minutes.
Furthermore, another two cognitive performance
evaluations and postprandial blood sampling will be
completed at 60 and 120 minutes. Figure 2 shows the
Standard Protocol Items: Recommendations for
Interventional Trials (SPIRIT) diagram for the trial
procedure.
Intervention
Each of the three scheduled visits will last 2 hours, 40 mi-
nutes; this will occur between 8:15 am and 10:55 am.
Participants will be asked to fast for 12 hours overnight
prior and to limit their physical activity, alcohol con-
sumption and smoking during the previous 24–48 hours.
Nutritional composition of each intervention arm
The nutritional composition of each intervention arm is
described as follows:
1. Control condition (BF-1):
This will consist of 350 mL of water served at room
temperature.
2. High glycaemic index breakfast (BF-2):
This will consist of 350 mL of water served at room
temperature, 200 mL of grape juice (with 569 kJ/
136 kcal), 40 g of white bread (2 slices of 218 kJ/
52 kcal each) and 29 g of strawberry jam (with
313 kJ/75 kcal), providing a total of 1318 kJ/315 kcal.
The nutrient composition of this meal is 72.0 g
Fig. 2 SPIRIT diagram. * Randomly assigned breakfast
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(91.4 %) carbohydrate, 0.9 g (2.6 %) fat, 3.9 g (5 %)
protein and 1.6 g (1 %) fibre, with an overall GI of 64.0.
3. Low glycaemic index breakfast (BF-3):
This will consist of 350 mL of water served at room
temperature, a 150-g apple (with 339 kJ/81 kcal), a
125-g low-fat natural yogurt (with 234 kJ/56 kcal), 3
shelled walnuts (with 163 kJ/39 kcal per unit) and
17.5 g of 72 % dark chocolate (with 427 kJ/102 kcal),
supplying a total of 1489 kJ/356 kcal. The nutrient
composition of this meal is 31.5 g (35.4 %) carbohy-
drate, 19.9 g (50.3 %) fat, 9.7 g (10.9 %) protein and
6.0 g (3.4 %) fibre, with an overall GI of 29.4.
Blinding strategy
Because of the nature of the interventions, participants
and research staff cannot be blinded. However, those
responsible for statistical analysis will be blinded to the
interventions.
Variables and measurement instruments
Sociodemographic variables
At the time of study entry and prior to the first interven-
tion visit, data on age, gender, marital status, educational
level and occupation will be collected.
Lifestyle-related variables
The following lifestyle-related variables will be collected
at the time of study entry and prior to the first interven-
tion visit:
1. Smoking:
This will be measured using a questionnaire on
smoking history and tobacco consumption pattern.
2. Alcohol consumption:
This will be measured using a questionnaire on
alcohol consumption in the past 7 days specifying
drinks and their volumes.
3. Regular diet:
This will be assessed with the Diet Quality Index
(DQI) [34], which is a validated questionnaire that
records the frequency of food intake and assigns a
score ranging from 18 to 54 points.
4. Regular physical activity:
This will be evaluated with the short version of the
International Physical Activity Questionnaire (IPAQ)
[35], validated for a Spanish population. It assesses
activity in the last 7 days differentiating between
three types (walking, moderate-intensity and
vigorous-intensity activity), according to the energy
expenditure estimated for each of them (3.3, 4 and 8
metabolic equivalents of task [MET], respectively). It
allows the MET-minutes/week to be calculated and
subjects to be classified according to three activity
levels (low, intermediate and high).
Female-specific variables
The date of the last menstruation will be recorded, be-
cause it may impact the study variables.
Anthropometric variables
The height will be measured, with the subject standing
barefoot, to record the average of two readings rounded
to the nearest centimetre using a portable system
(Seca 222; Medical scale and measurement system,
Birmingham, UK).
The body weight will be measured, with the subject
barefoot and wearing light clothing, to record the average
of two readings rounded to 100 g using a standard elec-
tronic balance (Seca 770; Medical scale and measurement
system, Birmingham, UK) that is properly calibrated
(precision ± 0.1 kg).
Following the recommendations of the Spanish Society
for the Study of Obesity (SEEDO) [36], the waist circum-
ference will be measured in duplicate at the level of the
midpoint between the last rib and the iliac crest (with
the subject standing without clothing) using a flexible
tape parallel to the floor after inspiration. Hip circumfer-
ence will be similarly measured at the level of the
trochanters.
Peripheral blood pressure
Three measurements of systolic (SBP) and diastolic (DBP)
blood pressure will be performed using the average of the
last two with a validated Omron M10-IT model sphygmo-
manometer (Omron Healthcare, Kyoto, Japan). The mea-
surements will be made on the participant’s dominant arm
in a seated position after at least 5 minutes of rest with a
cuff of appropriate size as determined by measurement of
the upper arm circumference and following the recommen-
dations of the European Society of Hypertension [37].
Arterial stiffness and central haemodynamic parameters
The Mobil-O-Graph® device [38] will be used to estimate
cardiac output and total peripheral vascular resistance
and to measure central blood pressure (CBP), pulse wave
velocity (PWV), reflection coefficient and augmentation
index (AIx). This is affected by heart rate (HR), so its
values will be corrected to an HR of 75 bpm. This device
will be scheduled to perform continuous measurements at
–10, 0, 15, 30, 45, 60, 75, 90, 105 and 120 minutes with
the subject sitting and resting his arm on a rigid surface.
Laboratory variables
At the time of study entry and prior to the first interven-
tion visit, fasting plasma creatinine, serum total cholesterol,
high-density lipoprotein (HDL) cholesterol, low-density
lipoprotein (LDL) cholesterol and triglyceride values will
be determined using standard enzymatic automated
methods.
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During each study visit, three cannula blood samples
will be collected at –10, 60 and 120 minutes to measure
serum glucose and insulin levels by ultraviolet-visible
spectrophotometry and chemiluminescence, respectively.
Serum will be isolated by centrifugation and stored in
a –20 °C freezer within 48–72 hours until analysis.
Samples will be treated and centrifuged by a single
researcher under standardised conditions. The analysis
will be performed in a laboratory in external quality
assurance programs of the Spanish Society of Clinical
Chemistry and Molecular Pathology.
Cognitive performance evaluation variables
For each of the three visits and for each evaluation
within the same visit, a list of 15 different words from
the Rey Auditory Verbal Learning Test and its alterna-
tive versions [39–41] will be used to evaluate the imme-
diate verbal memory via immediate recall over three
attempts. Delayed verbal memory will be assessed by
free recall of the words learnt in the first part of the
evaluation after a period of 10 minutes. Phonological flu-
ency will be explored by enumerating for one minute as
many words as possible starting with different letters
[42]. The Trail Making Test A will be used to assess at-
tention and processing speed, while executive functions
will be explored using the Trail Making Test B [43].
Working memory will be traced with the WAIS Digit
Span Backward test [44]. Finally, sustained and selective
attention, executive functions and processing speed will
be explored with the Stroop test [45].
Statistical analysis
The normal distribution of variables will be verified
using a Kolmogorov-Smirnov test. Quantitative variables
will be displayed as the mean ± standard deviation if nor-
mally distributed or as the median (interquartile range) if
asymmetrically distributed. The data will be quantitated
using the repeated measures for analysis of variance
(ANOVA) or the Friedman test if the data are non-
normally distributed. To compare the differences among
the three types of breakfast, the ANOVA test will be used,
or the Wilcoxon test if the data are non-normally distrib-
uted. We will use the least significant difference (LSD) test
as post hoc analysis. The relationship of quantitative
variables to each other will be tested using Pearson’s or
Spearman’s correlation as appropriate. The effect of the
interventions can be modified by conditions such as the
last menstruation date. To control the effect of con-
founders on the study results and to adequately evaluate
the effect of the interventions, a multivariate analysis will
be performed using the general linear model (GLM) in
basic or extended models. The contrasting hypothesis will
establish an alpha risk of 0.05 as the limit of statistical
significance. The data will be analysed using IBM’s SPSS
Statistics for Windows version 23.0 (IBM Corporation,
Armonk, NY, USA).
Methodological limitations
This study follows all the Consolidated Standards of
Reporting Trials (CONSORT) recommendations, but
participants cannot be blinded due to the intervention
characteristics. However, the investigator who analyses
the data will be blinded.
The acute effect of the high or low glycaemic index
breakfast on the study variables may be influenced by
conditions that cause endothelial dysfunction such as
hypertension, diabetes or dyslipidaemia. Therefore, sub-
jects with CVD, hypertension, diabetes or dyslipidaemia
will be excluded.
Attempts to standardise food intake prior to experi-
mental trials will not be made. However, participants will
be asked to maintain stable dietary habits.
Discussion
There is accumulating evidence that postprandial gly-
caemic response is associated with cognitive and vascu-
lar function [18, 23]. To our knowledge, the postprandial
effects of high and low glycaemic index (GI) breakfasts
on vascular parameters and cognitive performance have
not been previously concurrently investigated.
Contrasting results have been reported about the effect
of breakfast on vascular function and haemodynamic pa-
rameters [21, 22]. In this project, we expect to demon-
strate that the lower glycaemic response to a low GI
breakfast will have a greater lowering effect on measures
of vascular function relative to a high GI breakfast.
Secondly, based on the findings of previous studies
conducted on children and adolescents [26–30, 32], we
hypothesise that we will see similar effects in healthy
young adults. Thus, we expect that the lower glycaemic
response to a low GI breakfast will have a positive im-
pact on immediate and delayed verbal memory and ver-
bal fluency, while the corresponding higher glycaemic
response to a high GI breakfast will positively affect at-
tention, processing speed and working memory.
Therefore, according to our hypothesis, the results of
the current study may explain the influence of GI on
cognitive and vascular function. Moreover, given the
high worldwide prevalence of cardiovascular disease and
its close relationship with cognitive decline, it would be
interesting to know how the vascular parameters and
cognitive processes are affected by the type of breakfast
consumed. This could be employed for the design of
novel lifestyle and dietary interventions.
Finally, our results may provide tools for adapting
breakfast composition to the type of task to be performed
and consequently for improving work performance.
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Trial status
This trial is currently recruiting participants.
Additional file
Additional file 1: Populated SPIRIT checklist. (PDF 55 kb)
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